Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Germany's Merck KGaA is nearing a deal for SpringWorks Therapeutics, a source close to the deal said on Thursday. Shares of ...

Shares of SpringWorks Therapeutics climbed after The Wall Street Journal reported that Germany's Merck KGaA is nearing a $3.5 billion deal for the U.S. biopharmaceutical company. SpringWorks stock ...

Germany’s Merck KGaA is finally nearing a roughly $3.5 billion deal for SpringWorks Therapeutics, a U.S. biopharmaceutical ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...

The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T cell ...

US-China trade de-escalation is less certain Germany IFO business climate beat forecasts Adidas rises 1.9% after upbeat earnings DAX recovery runs into resistance USD/JPY Falls as US-China ...

Deutsche Bank's Chief Investment Officer and chief strategist from private bank Merck Finck gives advice on how to protect ...

Friedrich Merz of the CDU is expected to become the next chancellor, replacing Olaf Scholz after Germany's center-right Christian Democratic Union (CDU) and center-left Social Democrats agreed to ...